Monday, December 29, 2008

FDA approves drug for eyelash growth

The makers of Botox have gotten FDA approval for a new drug that will stimulate eyelash growth.

Latisse, which is designed to treat a condition known as hypotrichosis of the eyelashes, which means a person does not have enough eyelashes, has been approved by the Food and Drug Administration (FDA).

When applied once daily to the eyelid with a disposable applicator, the drug Latisse apparently improves the length, thickness and colour of hairs.

Continued use is necessary to maintain the thicker lashes, and side effects can include eye redness and itchiness, a darkening of the eyelid skin and a permanent darkening of the whites of the eyes.

So, you get long beautiful lashes and red itchy eyes. Sounds delightful.

The drug is expected to cost around $120. My great lash only costs $3.00 and it makes my lashes darker and longer without the yucky side effects.

No comments: